BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu J, Li M, Wu DC, Liu LL, Chen SL, Yun JP. Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma. Transl Oncol 2015;8:400-6. [PMID: 26500030 DOI: 10.1016/j.tranon.2015.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Rust MB, Khudayberdiev S, Pelucchi S, Marcello E. CAPt'n of Actin Dynamics: Recent Advances in the Molecular, Developmental and Physiological Functions of Cyclase-Associated Protein (CAP). Front Cell Dev Biol 2020;8:586631. [PMID: 33072768 DOI: 10.3389/fcell.2020.586631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Saker Z, Bahmad HF, Fares Y, Al Najjar Z, Saad M, Harati H, Nabha S. Prognostic impact of adenylyl cyclase-associated protein 2 (CAP2) in glioma: A clinicopathological study. Heliyon 2020;6:e03236. [PMID: 32042970 DOI: 10.1016/j.heliyon.2020.e03236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hasan R, Zhou GL. The Cytoskeletal Protein Cyclase-Associated Protein 1 (CAP1) in Breast Cancer: Context-Dependent Roles in Both the Invasiveness and Proliferation of Cancer Cells and Underlying Cell Signals. Int J Mol Sci 2019;20:E2653. [PMID: 31151140 DOI: 10.3390/ijms20112653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
4 Yan H, Guan Q, He J, Lin Y, Zhang J, Li H, Liu H, Gu Y, Guo Z, He F. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues. J Transl Med 2017;15:26. [PMID: 28178989 DOI: 10.1186/s12967-017-1122-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
5 Adachi M, Masugi Y, Yamazaki K, Emoto K, Kobayashi Y, Tominaga E, Banno K, Aoki D, Sakamoto M. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes. Jpn J Clin Oncol 2020;50:643-52. [PMID: 32211793 DOI: 10.1093/jjco/hyaa026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li L, Fu LQ, Wang HJ, Wang YY. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer. Pathol Oncol Res 2020;26:273-9. [PMID: 30047046 DOI: 10.1007/s12253-018-0450-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ge S, Wang S, Xiang W, Wang L, Zhu Y, Zhu X, Wang X, Zuo L, Jiang C, Li S, Liu M. [Association of adenylate cyclase-associated protein 2 expression with histopathology and long-term prognosis of gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1052-8. [PMID: 31640951 DOI: 10.12122/j.issn.1673-4254.2019.09.08] [Reference Citation Analysis]
8 Xie S, Shen C, Tan M, Li M, Song X, Wang C. Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer. Oncotarget 2017;8:27216-39. [PMID: 28423713 DOI: 10.18632/oncotarget.16111] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]